Author

Chenxi Zhu

Tongji UniversityORCID 0000-0003-4740-585XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Dapeng ZhouiD· 2 shared Chunchao Feng· 1 shared Hailin TangiD· 1 shared Jingxia WangiD· 1 shared Ping Zhao· 1 shared Rong ZhangiD· 1 shared Wang NianiD· 1 shared Wen ZhangiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Dapeng ZhouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyAntiviral ResearchPeer-reviewedSep 3, 2025

DMBT1 promotes SARS-CoV-2 infection and its SRCR-derived peptide inhibits SARS-CoV-2 infection

Chenxi Zhu, Ziqiao Wang, Zhendong Pan…·Dapeng Zhou

This study identifies DMBT1 as a co-receptor for SARS-CoV-2 infection and shows a SRCR-derived peptide can inhibit it.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintMar 22, 2025

A humanized 16A antibody conjugated with DNA topoisomerase I inhibitors, targeting a GSTA glycosite-signature epitope.

Yu He, Zhaohui Ji, Wang Nian…·Dapeng Zhou

This paper evaluates the antitumor efficacy of humanized 16A antibody conjugates with DNA topoisomerase I inhibitors, showing potent in vitro and in vivo activity against MUC1-expressing tumors.

DOI 10.1101/2025.03.22.644720

humanproteomics

𝕏 PostBluesky